Skip to main content

Table 2 Descriptive and result table of 26 studies categorized as proof-of-concept research

From: From blood drops to biomarkers: a scoping review of microsampling in mass spectrometry-based proteomics

First author

Year

Sample types

Microsample details:

- Volume of blood

- Punch diameter or area (DBS only)

- Collection device (manufacturer)

Microsample collection method

Notable sample preparation

Acquisition method

Effective gradient length

(min)

Throughput

Quantification

Targeted

Untargeted

Chambers [28]

2013a

DBS/DPS/DSS

- 15 µL

- Entire spot

- 903 Protein Saver (Whatman)

Plasma

Serum

WB

Venous blood deposited onto DBS

NA

NA

DDA

Orbi-q-IT

90

253 proteins (1549 peptides)

No quantification

Chambers [50]

2013b

DBS

- 15 µL

- Entire spot

- 903 Protein Saver (Whatman)

Venous blood deposited onto DBS

NA

MRM

NA

NA

37 proteins (40 peptides)

Calibration curve with SIS peptides

Martin [29]

2013

DBS

- Ahlstrom grade 226 filter paper (ID Biological Systems)

Finger prick

Liquid extraction surface analysis to extract proteins

NA

DDA

Orbi-q-IT

30

120 proteins

No quantification

Chambers [49]

2015

DBS

- 15 µL

- Entire spot

- 903 Protein Saver (Whatman)

Venous blood deposited onto DBS

NA

MRM

NA

NA

97 proteins (169 peptides)

PAR relative to SIS peptides

LLOQ: 190 ng/mL (cholinesterase)

Geyer [39]

2016

Plasma

- 1 µL

- Custom pipette tip-based centrifugal devices

Finger prick

Basic reverse-phase fractionation (high throughput method)

NA

DDA

Orbi-q-Orbi

15

100

347 proteins (short gradient)

1040 proteins (long gradient)

LFQ

Cox [46]

2017a

DBS

- 20 µL

- Entire spot

- DMPK-C (Whatman)

Venous blood deposited onto DBS

Buffer washing to enrich membrane proteins

PRM

NA

NA

4 proteins (4 peptides)

PAR relative to SIS peptides

Henderson [44]

2017

DBS

- 65 µL

- 1 × 3.2 mm

- 903 Protein Saver (Whatman)

Plasma

Finger prick by trained personnel

Venous blood deposited onto DBS

NA

PRM

NA

NA

3 proteins (6 peptides)

Peak area integration of transitions

LLOQ: 8.3 mg/dL (apolipoprotein B)

Ozcan [53]

2017

DBS

- 1 × 3 mm

- 903 Protein Saver (Whatman)

Serum

Finger prick

NA

MRM

NA

NA

82 proteins (156 proteins)

PAR relative to SIS peptides

van den Broek [88]

2017

Plasma

VAMS

- 10 µL

- Mitra (Neoteryx)

VAMS dipped into venous blood

NA

SRM

DIA

SWATH-MS

60

SRM: 6 proteins (10 peptides)

PAR relative to SIS peptides

DIA: 423 proteins (1661 peptides)

LFQ

Wouters [89]

2017

DBS

- 10 µL

- Entire spot

- Human ID Blood stain Card BFC 180 (Whatman)

Finger prick

Immobilized enzyme reactor for digestion

NA

DDA

TOF-q-TOF

45

156 proteins

No quantification

Forchelet [37]

2018

Microsample

- 20–25 µL resulting in

2 µL sample

- Custom microfluidic device

Plasma

Serum

Finger prick

NA

NA

DIA

SWATH-MS

ND

312 proteins

LFQ

Rosting [90]

2018

DBS

- Entire spot

- Ahlstrom grade 226 (ID Biological Systems)

Finger prick

Liquid surface extraction analysis to extract proteins

NA

DDA

Orbi-q-IT

30

350 proteins (1065 peptides)

No quantification

Samenuk [91]

2019

NBS

- ¼ of spot

ND

NA

NA

MALDI-TOF

ND

30 peptides

No quantification

Vidova [52]

2019

DBS

- 1 × 3 mm

- 903 Protein Saver (Whatman)

Serum

WB

Finger prick

NA

SRM

NA

NA

7 proteins (13 peptides)

PAR relative to SIS peptides

LLOQ: 0.8 nM (serum amyloid A4)

Eshgi [41]

2020

DBS

- 50 µL

- 5 × 6 mm

- 903 Protein Saver (Whatman)

WB

Venous and capillary blood deposited onto DBS

NA

MRM

NA

NA

245 proteins

PAR relative to SIS peptides

LLOQ: 0.2 fmol

Nakajima [42]

2020

DBS

- 2 × 3.2 mm

- Blood sampling paper (Advantec)

Finger prick

Sodium carbonate precipitation to reduce soluble proteins

NA

DIA

Orbi-q-Orbi

75

1977 proteins

LFQ

van den Broek [92]

2020

VAMS

- 10 µL

- Mitra (Neoteryx)

Finger prick, both self-sampled and by trained personnel

NA

SRM

NA

NA

11 proteins (22 peptides)

PAR relative to SIS peptides

Cox [47]

2021

DBS

- 20 µL

- Entire spot

- DMPK-C (Whatman)

Venous and capillary blood deposited onto DBS

Buffer washing to enrich membrane proteins

PRM

NA

NA

4 proteins (4 peptides)

PAR relative to SIS peptides

LLOQ: 0.135 nM (CD71)

Mc Ardle [93]

2022

Plasma

VAMS

- 10 µL

- Mitra (Neoteryx)

VAMS dipped into venous blood

NA

NA

DIA

Orbi-q-Orbi

21

60

939 proteins

LFQ

Schneider [94]

2022

DBS

- 50 µL

- 1 × 3 mm

- 903 Protein Saver (Whatman)

Venous blood deposited onto DBS

NA

NA

DIA

Orbi-q-Orbi

90

 ~ 400 proteins (~ 3000 peptides)

LFQ, peptide ratios

Whelan [30]

2023

Plasma

VAMS

- 10 µL

- Mitra (Neoteryx)

Finger prick, self-sampled

VAMS dipped into venous blood

NA

MRM

DIA

Orbi-q-Orbi

60

MRM: 60 proteins (114 peptides)

PAR relative to SIS peptides

DIA: 4661 proteins

No quantification

Brockbals [35]

2024

DBS

- 20 µL

- 1 × 3 mm

- 903 Protein Saver (Whatman)

Venous and capillary blood deposited onto DBS

NA

MSMS with inclusion list

NA

NA

3 proteins (11 peptides)

Peptide ratios

Richard [95]

2024

DBS

- 20 µL

- 4 × 6 mm

- 903 Protein Saver (Whatman)

Finger prick

NA

MRM

NA

NA

250 proteins (319 peptides)

PAR relative to SIS peptides

Shen [96]

2024

VAMS

- 10 µL

- Mitra (Neoteryx)

Finger prick, self-sampled

Biphasic MTBE extraction to precipitate protein pellet

NA

DIA

SWATH-MS

43

291 proteins

LFQ

Sun [51]

2024

Blood cells

DBS

- 100 µL

- Entire spot

- FTA card (Qiagen)

Plasma

WB

Venous blood deposited onto DBS

NA

NA

DDA

Orbi-q-Orbi

78

758 proteins (7348 peptides)

LFQ

Vegesna [97]

2025

DBS

- 903 Protein Saver (Whatman)

VAMS

- Mitra (Neoteryx)

Plasma

VAMS dipped into whole blood or plasma

Venous blood deposited onto DBS

NA

NA

DIA

Orbi-q-Orbi

60

ND

LFQ

  1. Both microsample and standard blood sample types were listed, and additional details were described for only for microsamples, including the volume of blood used in the microsample if measured precisely, the punch size (DBS samples only), and the microsample collection device. Any sample preparation steps outside of reduction/alkylation, digestion and sample cleanup were reported. The acquisition strategy was reported. For untargeted studies, the effective gradient was described, defined as the length of time from 2 to 5% organic solvent to 20–45% organic solvent where peptides were actively eluting from the column during reverse-phase high-performance liquid chromatography. Throughput described the maximum number of proteins and/or peptides identified based on analysis of microsamples. Quantification strategies were specified and the LLOQ was reported if assessed
  2. DBS: dried blood spot; DDA: data-dependent acquisition; DIA: data-independent acquisition; DPS: dried plasma spot; DSS: dried serum spot; IT: ion trap analyzer; LLOQ: lower limit of quantification; LQF: label-free quantification; MRM: multiple reaction monitoring; MTBE: methyl tert-butyl ether; NA: not applicable; NBS: newborn dried blood spot; ND: not described; Orbi: Orbitrap analyzer; PAR: peak area ratio; PASEF: parallel accumulation—serial fragmentation; PRM: parallel reaction monitoring; q: quadrupole isolation; SIS: stable isotope-labeled standard; SRM: single reaction monitoring; SWATH-MS: Sequential Windowed Acquisition of all Theoretical Mass Spectra; TOF: time-of-flight analyzer; VAMS: volumetric absorptive microsampling